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I enjoyed the article by Ramezani et al., ‘‘Detection of
hepatitis G virus envelope protein E2 antibody in blood
donors,’’ published in a recent issue of the International
Journal of Infectious Diseases,1 and would like to make some
comments on this article.
Firstly, the authors evaluated hepatitis G virus (HGV)
antibody and ribonucleic acid (RNA) among 478 blood donors
in Tabriz City, but then went on to reflect their results onto
the whole population of Iranian blood donors. Iran is a
country with a population of more than 70 000 000, and a
survey in the northwest of the country, on 478 samples,
cannot be representative of the HGV status for all Iranian
blood donors. The pattern of prevalence of hepatitis G may
well be different in the various other regions of Iran. For
example, Gharebaghian et al. showed the hepatitis G pre-
valence in Tehran, the capital of Iran, to be 4.2% among 330
blood donors,2 a higher prevalence value than that deter-
mined by Ramezani et al. The current prevalence of virus in
other parts of the country remains to be elucidated, and then
a meta-analysis will determine the countrywide pattern.
Secondly, in liver function tests, the mean levels of ALTand
ASTwere cited for both groups — thosewith positive results forHGV and those with negative results for HGV; however, no
reference rangeswere given, whichmakes the description and
interpretation of the results somehow confusing.
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Dear Dr Cameron
Thank you for sending me the letter from H. Mansouri-
torghabeh concerning my article entitled ‘‘Detection of
hepatitis G virus envelope protein E2 antibody in blood
donors,’’ published in the International Journal of Infectious
Diseases.In reply to the first point made, because Tabriz City is not
well known to scholars around the world, we used ‘Iran’ in
the ‘Aims’ section to give readers an immediate understand-
ing of the place of study; however in the ‘Patients and
methods’ section it was explained that the study took place
in Tabriz City. This policy is common inmany papers published
in international journals.1—5 Also, we did not reflect our
results onto all Iranian blood donors. As mentioned in the
‘Discussion’ section, ‘‘We have shown a low frequency of
446 Correspondenceanti-E2 (1%) in blood donors accepted at the Tabriz blood
transfusion center’’.
In reply to the second point, the reference ranges of ALT
and AST are cited in referral clinical laboratory texts6,7 and
are available to all scholars.
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safety in infectious diseases
To our knowledge, Widal, late in the 19th century, was the
first to puncture the spleen for the diagnosis of typhoid fever.
Since then, splenic aspiration has been widely used around
the Mediterranean Basin and in Asia in the diagnosis of
leishmaniasis, trypanosomiasis, and malaria. We present
herein a brief review of the use of this technique with regard
to its utility and safety in the diagnosis of infectious diseases,
and share our experiences of its use in the diagnosis of
brucellosis.
Cysts, abscesses,1 and a variety of infectious and granu-
lomatous processes2 involving the spleen can be diagnosed by
puncture. Although various complications of this technique,
including pneumothorax, left shoulder pain, and hemoptysis,
have been reported, uncontrolled bleeding resulting in death
or requiring a splenectomy is rare.3 In over 1000 aspirations,
Soderstrom4 experienced no complications. Kumar et al.,5 in
their study of 48 cases, concluded that splenic aspiration is a
safe and very useful procedure in the diagnosis of parasitic
and infectious diseases. The experiences of Lal et al.6 and
Venkataramu et al.7 have also demonstrated the excellent
diagnostic accuracy and safety of splenic aspiration in both
neoplastic and infectious splenic disorders. In the latter
study, acid-fast bacilli were demonstrated in 10 patients,
aspergillus in one, and one was diagnosed as having histo-
plasmosis.7
The diagnostic yield has been found to be higher for
splenic aspiration than for other specimens in visceral leish-
maniasis (as high as 98% vs. <90%, respectively).8 Recently,
splenic aspiration has been used for the diagnosis of splenicabscess as a complication of enteric fever by isolating Sal-
monella typhi in a patient whose cultures of blood, urine, and
stool were sterile.9 Also, the recent use of computed tomo-
graphy (CT)-guided percutaneous aspiration for the diagnosis
of splenic abscess has shown encouraging results.10
To-date, no attempts have been made to puncture the
spleen in a living subject for the diagnosis of brucellosis.
Hence, we conducted a comparative evaluation of blood,
bone marrow, splenic (ultrasound-guided), liver, and lymph
node aspirate cultures in 13 patients who were seroposi-
tive for brucellosis (standard tube agglutination test
1:160), and who had clinical features suggestive of bru-
cellosis along with an epidemiological indication. The
specimens were cultured simultaneously using Castaneda’s
biphasic media consisting of brain heart infusion agar and
broth or trypticase soy agar and broth, and were processed
according to standard methods.11 It was found that bone
marrow specimens were sterile in 46% (6/13) of cases when
bacteremia was present, but Brucella melitensis was
detected in the splenic aspirate in these six bacteremic
cases. In one patient for whom the blood was sterile, the
splenic aspirate yielded B. melitensis. These results indi-
cate that the brucellae are not uniformly distributed in the
bone marrow and also that adopting the practice of cul-
turing splenic aspirates may enhance bacterial isolation
and aid in the establishment of the diagnosis of brucellosis.
No evidence of morbidity, such as hemorrhage, was
encountered.
To make this technique safe, it is wise initially to confine
the performance of the procedure to a few hands until they
become more familiar with it. In our experience, with a
small bore needle, splenic aspiration is safe and can be a
